8-K: Phreesia Reports Strong Q3 FY26, Boosts Outlook & Completes AccessOne Acquisition

Phreesia announced robust third-quarter fiscal 2026 results, exceeding revenue and Adjusted EBITDA expectations, and completed its strategic $160 million acquisition of AccessOne, enhancing its healthcare financing solutions.

Summary

• Total revenue for the third fiscal quarter ended October 31, 2025, was $120.3 million, marking a 13% increase year-over-year.
• The company achieved a net income of $4.3 million in Q3 FY26, a significant improvement from a net loss of $14.4 million in the same period of the prior year.
• Adjusted EBITDA for Q3 FY26 reached $29.1 million, substantially up from $9.8 million in Q3 FY25.
• Net cash provided by operating activities was $15.5 million in Q3 FY26, compared to $5.8 million in Q3 FY25.
• Free cash flow for the quarter was $8.8 million, an increase from $1.6 million in Q3 FY25.
• Cash and cash equivalents stood at $106.4 million as of October 31, 2025, an increase of $22.2 million from January 31, 2025.
• The acquisition of AccessOne Parent Holdings, Inc. for approximately $160 million in cash consideration was completed on November 12, 2025, funded by cash and a new $110 million secured term loan.
• The fiscal 2026 revenue outlook was updated to a range of $479 million to $481 million (from $472 million to $482 million), including approximately $7.5 million from AccessOne.
• The fiscal 2026 Adjusted EBITDA outlook was updated to a range of $99 million to $101 million (from $87 million to $92 million), incorporating AccessOne contributions.
• The company introduced its fiscal 2027 revenue outlook, expecting a range of $545 million to $559 million, representing a 14-16% increase over the fiscal 2026 outlook.
• Fiscal 2027 Adjusted EBITDA is projected to be in the range of $125 million to $135 million.
• The average number of healthcare services clients (AHSCs) grew 7% year-over-year to 4,520 in Q3 FY26.
• Total revenue per AHSC increased 6% year-over-year to $26,622 in Q3 FY26.
• New product features, including Refill Reminders and Push-to-Mobile Wallet for patient payments, were launched.
• Phreesia received Year 2 grant funding from the Centers for Disease Control and Prevention (CDC) for urinary incontinence outreach and launched a skin cancer awareness initiative with Prevent Cancer Foundation.

Sentiment

Score: 9

Explanation: The company reported strong financial results with significant year-over-year growth in revenue, net income, Adjusted EBITDA, and cash flow. The successful acquisition of AccessOne expands its market reach into a high-growth area, and the updated fiscal 2026 and introduced fiscal 2027 outlooks are very positive, indicating continued strong performance and strategic execution. Product innovations and industry recognition further bolster a highly positive sentiment. The only minor concern is the increasing interest rate on the bridge loan, but the company plans to refinance.

Positives

• Total revenue increased by 13% year-over-year to $120.3 million in Q3 FY26, demonstrating strong top-line growth.
• Achieved net income of $4.3 million in Q3 FY26, a significant turnaround from a net loss of $14.4 million in Q3 FY25.
• Adjusted EBITDA surged to $29.1 million in Q3 FY26, a substantial increase from $9.8 million in Q3 FY25, indicating improved operational efficiency and profitability.
• Net cash provided by operating activities improved significantly to $15.5 million in Q3 FY26 from $5.8 million in Q3 FY25.
• Generated positive free cash flow of $8.8 million in Q3 FY26, up from $1.6 million in Q3 FY25.
• Maintained a healthy cash and cash equivalents balance of $106.4 million as of October 31, 2025, an increase of $22.2 million since January 31, 2025.
• Successfully completed the strategic acquisition of AccessOne for approximately $160 million, expanding into the high-growth provider financing market.
• Upgraded fiscal 2026 revenue outlook to $479 million $481 million (from $472 million $482 million), reflecting strong performance and AccessOne contribution.
• Significantly raised fiscal 2026 Adjusted EBITDA outlook to $99 million $101 million (from $87 million $92 million), indicating enhanced profitability expectations.
• Introduced a robust fiscal 2027 outlook with expected revenue growth of 14-16% ($545 million $559 million) and Adjusted EBITDA of $125 million $135 million.
• Average number of healthcare services clients (AHSCs) grew 7% year-over-year to 4,520, demonstrating continued client acquisition.
• Total revenue per AHSC increased 6% year-over-year to $26,622, indicating increased value generation from existing clients.
• Launched innovative product features like Refill Reminders and Push-to-Mobile Wallet, enhancing patient experience and provider collections.
• Received industry recognition, including being named to the 2025 Deloitte Technology Fast 500 and TIMEs 2025 Worlds Top HealthTech Companies list.
• Secured Year 2 grant funding from the CDC for urinary incontinence outreach and initiated a skin cancer awareness campaign, highlighting commitment to public health initiatives.

Negatives

• Payment processing expense as a percentage of payment processing fees revenue increased to 72% in Q3 FY26, up from 71% in Q2 FY26 and 68% in Q3 FY25, indicating a slight decrease in efficiency for this revenue stream.
• The take rate percentage for payment processing declined to 2.7% in Q3 FY26, from 2.8% in both Q2 FY26 and Q3 FY25, a result of a strategic flexible pricing model to drive higher payment facilitator attachment.
• The $110 million Bridge Loan for the AccessOne acquisition has an interest rate that increases by 0.5% every three months, necessitating timely refinancing to avoid higher costs.

Risks

• Ability to effectively manage growth and meet growth objectives.
• Ability to integrate operations or realize any operational or corporate synergies and other benefits from the AccessOne Acquisition.
• The competitive environment in which the company operates.
• Ability to comply with the covenants in the Capital One Credit Facility and the Bridge Loan.
• Changes in market conditions and receptivity to products and services.
• Ability to develop and release new products and services and successful enhancements, features, and modifications to existing products and services.
• Ability to maintain the security and availability of the platform.
• The impact of cyberattacks, security incidents, or breaches impacting the business.
• Changes in laws and regulations applicable to the business model and AccessOne's business model.
• Ability to make accurate predictions about the industry and addressable market.
• Ability to attract, retain, and cross-sell to healthcare services clients.
• Ability to continue to operate effectively with a primarily remote workforce and attract and retain key talent.
• Ability to realize the intended benefits of acquisitions and partnerships.
• Difficulties in integrating acquisitions and investments.
• Artificial intelligence that can impact the business, including by posing security risks to confidential information, proprietary information, and personal data, increasing regulatory and compliance burden, and increasing competition.
• Other general, market, political, economic, and business conditions (including from the U.S. federal government, tariff and trade issues, and warfare and/or political and economic instability in Ukraine, the Middle East, or elsewhere).
• Risks related to obtaining long-term financing to refinance the Bridge Loan on favorable terms in a timely manner or at all.
• Uncertainty and potential variability of other (income) expense, net and income tax (benefit) expense, which are reconciling items between Adjusted EBITDA and GAAP net income (loss), making a reconciliation of the non-GAAP financial measure outlook to the corresponding GAAP measure not available without unreasonable effort.

Future Outlook

Phreesia updated its fiscal 2026 revenue outlook to $479 million to $481 million, including approximately $7.5 million from the AccessOne acquisition, and its Adjusted EBITDA outlook to $99 million to $101 million, reflecting AccessOne contributions and continued operating leverage. The company also raised its fiscal 2026 expectation for AHSCs to approximately 4,515. For fiscal 2027, Phreesia introduced a revenue outlook of $545 million to $559 million, representing a 14-16% increase over fiscal 2026, with AccessOne expected to contribute about 6.5% of total revenue. Fiscal 2027 Adjusted EBITDA is projected to be $125 million to $135 million, with AHSCs expected to grow in the mid-single-digit percent range and total revenue per AHSC in the low-double-digit percent range. The company believes its current liquidity and cash generation will be sufficient to meet these outlooks and obligations.

Management Comments

• "I am very proud of our teams strong execution in the fiscal third quarter, which is reflected throughout this letter from our revenue and profit results to product updates and client stories."
• "I am thrilled to bring AccessOne’s capabilities to Phreesia and welcome the team to our organization."
• "We believe these emerging products will enable us to sustain growth and enhance stakeholder value."
• "Our expansion into the provider financing market through the acquisition of AccessOne helps us solve this large and growing problem with a market-leading solution. We believe we have a new growth lever to complement our existing solutions for providers, and are excited about this opportunity."
• "Our approach differentiates Phreesia by closing the loop between patient and provider engagement."
• "By making HCP activation available within that same trusted ecosystem and centered on real care encounters—we believe it will deepen our relationships with both providers and life sciences clients, while adding a durable, differentiated revenue stream to Phreesia’s growth story."
• "Management believes adjusting for these acquisition-related costs provides investors with a more consistent period-to-period comparison of our core operating performance and trends."

Industry Context

The healthcare industry is experiencing a significant shift towards increased patient financial responsibility, leading to challenges for providers in managing receivables and cash flow. Hospitals and health systems have seen a 28% decline in days cash on hand since 2022, highlighting a critical need for efficient financing solutions. Phreesia's acquisition of AccessOne directly addresses this trend by expanding its offerings into provider financing, positioning itself to capture a share of the estimated $74 billion market for financed out-of-pocket spend. Furthermore, the company's expansion into healthcare provider (HCP) marketing leverages its established patient engagement platform, tapping into a multi-billion-dollar digital marketing opportunity. This strategy differentiates Phreesia by integrating patient and provider engagement within clinical workflows, aligning with the broader digital transformation and efficiency drives in healthcare.

Comparison to Industry Standards

• Hospitals and health systems have seen the number of days cash on hand decline by 28% since 2022, indicating a significant industry-wide challenge that AccessOne's financing solutions aim to mitigate.
• AccessOne manages a portfolio of approximately $450 million and generates a blended take rate averaging 4% to 12% on its managed portfolio, depending on provider type and funding model, providing specific operational benchmarks for the acquired entity.
• The market for financed out-of-pocket spend is estimated at $74 billion, based on CMS data for physician, clinical, and other professional services (2023) and Gallup's study on medical bill borrowings (2024), highlighting a substantial addressable market for Phreesia's new financing solutions.
• Up to 69% of medication-related hospital admissions are due to poor adherence, costing the U.S. an estimated $100 billion to $300 billion annually, underscoring the significant problem Phreesia's Refill Reminders feature aims to address.
• Phreesia was named to the 2025 Deloitte Technology Fast 500 and TIMEs 2025 Worlds Top HealthTech Companies list, indicating strong growth and innovation relative to other technology and health tech companies in North America and globally.

Corporate Governance

Stakeholder Impact

• Shareholders: Positive impact due to strong financial performance, increased profitability, positive cash flow, and an upgraded outlook. The strategic acquisition of AccessOne is expected to drive future growth and enhance long-term value.
• Healthcare Providers (Clients): Enhanced offerings through AccessOne (provider financing solutions to improve collections and cash flow), new product features like Push-to-Mobile Wallet (increased time-of-service collections), and Refill Reminders (reduced call volume, improved patient adherence).
• Patients: Improved affordability and experience through financing solutions (AccessOne), better medication adherence (Refill Reminders), more convenient payment options (Push-to-Mobile Wallet), and increased awareness/education for chronic conditions (UI, skin cancer campaigns).
• Employees: Welcome of AccessOne team members, continued focus on efficiency and operating leverage, and recognition of key talent (Sara DiNardo).
• Creditors: New $110 million Bridge Loan and amendments to the Capital One Credit Facility, indicating increased debt but also strategic growth. The company expects to refinance the Bridge Loan.

Next Steps

• Refinance or replace the $110 million Bridge Loan with a long-term credit facility.
• Continue to integrate AccessOne operations and realize operational and corporate synergies.
• Continue to develop and release new products and services, and enhance existing ones.
• Expand outreach for urinary incontinence education and awareness in Year 2 of the CDC grant.
• Contribute to and disseminate analyses of Year 1 CDC grant findings to further knowledge and support for women with UI.
• Hold a conference call on December 8, 2025, at 5:00 p.m. Eastern Time to review fiscal 2026 third-quarter financial results.
• File the Quarterly Report on Form 10-Q for the fiscal quarter ended October 31, 2025, with the SEC.

Key Dates

Recommendation

Phreesia has demonstrated exceptional financial performance in Q3 FY26, transitioning from a net loss to a net income and significantly boosting Adjusted EBITDA and cash flow. The strategic acquisition of AccessOne is a well-aligned move into the high-growth provider financing market, expected to contribute substantially to future revenue and profitability. The company's updated FY26 outlook and robust FY27 guidance signal strong confidence in sustained growth and operational efficiency. Product innovation and industry recognition further solidify its market position. While the Bridge Loan needs refinancing, the overall picture is one of strong execution, strategic expansion, and promising future prospects, making it a compelling investment opportunity.

Keywords

Healthcare technology, Patient activation, Financial results, Q3 earnings, AccessOne acquisition, Healthcare financing, Patient payments, Adjusted EBITDA, Revenue growth, Healthcare services clients, Digital health, Medical software, Patient engagement, Provider solutions, HealthTech, SEC filing, PHR